Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
for
Diabetic Macular Edema (DME)
Location: Arlington TX, Plano TX, Austin TX, Round Rock TX,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT07734844
Phase 3, Recruiting
Active & Responsive
Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study
for
Asthma Control, Pulmonary Function, Quality of Life, Stress,
Location: Southlake TX, Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: Motiva USA LLC
Sex: Female
Age: 22+
Code: NCT06938399
Recruiting
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
for
Moderate to Severe Psoriatic Arthritis
Location: Colleyville TX, Katy TX, San Antonio TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07801495
Phase 2, Recruiting
Active & Responsive
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
for
Sjögren´s Disease
Location: Euless TX, Leander TX, Oklahoma City OK, Houston TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07621809
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Colleyville TX, Tomball TX, Lake Charles LA, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Location: Southlake TX, Rolling Meadows IL, Anderson SC, Ocala FL,
Sponsor: Inmagene LLC
Sex: All
Age: 18 - 70+
Code: NCT07037901
Phase 2, Recruiting
Active & Responsive
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
for
Angiokeratomas
Location: Southlake TX, Dawsonville GA
Sponsor: Palvella Therapeutics, Inc.
Sex: All
Age: 6+
Code: NCT07552077
Phase 2, Recruiting
Active & Responsive
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
for
Center Involved Diabetic Macular Edema, Diabetic Macular Edema
Location: Southlake TX, Bellaire TX, La Crosse WI,
Sponsor: Ocugen
Sex: All
Age: 18+
Code: NCT05802329
Phase 1, Recruiting
Active & Responsive
A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
for
Chronic Pruritus of Unknown Origin
Location: Grapevine TX, San Antonio TX, Sugarland TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07811869
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer